Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19860

Title: Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study
Authors: Ziemssen, T.
Hobart, J.
Feys, Peter
Linnebank, M.
Goodman, A.
McNeill, M.
Zhong, J.
Mehta, L.
Issue Date: 2015
Citation: EUROPEAN JOURNAL OF NEUROLOGY, 22 (S1), p. 621-621
Notes: [Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Hobart, J.] Univ Plymouth, Peninsula Sch Med, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Hobart, J.] Univ Plymouth, Peninsula Sch Dent, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Feys, P.] Univ Hasselt, Diepenbeek, Belgium. [Linnebank, M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland. [Goodman, A.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA. [McNeill, M.] Biogen Idec Inc, Maidenhead, Berks, England. [Zhong, J.; Mehta, L.] Biogen Idec Inc, Cambridge, MA USA.
URI: http://hdl.handle.net/1942/19860
ISI #: 000364239000254
ISSN: 1351-5101
Category: M
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
N/A194.07 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.